Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Akeso, Inc.

Equities

9926

KYG0146B1032

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-05-14 EDT 		5-day change 1st Jan Change
49.2 HKD -0.10% Intraday chart for Akeso, Inc. +2.39% +6.03%
04-24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
04-24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Akeso, Inc. Announces Change of Role of Senior Management, Effective from May 3, 2023
CI
Akeso, Inc. Announces Resignation of Xi Xiaojie as Chief Financial Officer, May 3, 2023
CI
Akeso, Inc. Appoints Jason Ni as Senior Vice President
CI
Akeso, Inc. Announces Change of Non-Executive Directors
CI
Akeso, Inc. Announces Appointment of Zhang Xinfeng as Senior Vice President
CI
Akeso, Inc. Appoints Bradley Monk as Lead Gynecologic Oncology Advisor and Chair of the Steering Committee
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. News Akeso, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW